V D Garovic

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi request reprint Hypertension in pregnancy: an emerging risk factor for cardiovascular disease
    Vesna D Garovic
    Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, 200 First Street South West, Rochester, MN 55905, USA
    Nat Clin Pract Nephrol 3:613-22. 2007
  2. ncbi request reprint 23-year-old man with hypertension and flank trauma
    Guilherme H M Oliveira
    Mayo Graduate School of Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 77:1229-32. 2002
  3. ncbi request reprint Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia
    Vesna D Garovic
    Division of Nephrology and Hypertension Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
    Nephrol Dial Transplant 22:1136-43. 2007
  4. pmc Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause
    Virginia M Miller
    Departments of Surgery and Physiology and Biomedical Engineering, 200 1st St SW, Rochester, MN 55905, USA
    Biol Sex Differ 4:6. 2013
  5. pmc Mass spectrometry as a novel method for detection of podocyturia in pre-eclampsia
    Vesna D Garovic
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA
    Nephrol Dial Transplant 28:1555-61. 2013
  6. pmc Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study
    Iasmina M Craici
    Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Hypertension 61:1289-96. 2013
  7. doi request reprint Method of diagnosing pre-eclampsia
    Steven J Wagner
    Mayo Clinic, Division of Nephrology and Hypertension, 200 First Street SW, Rochester, Minnesota 55905, USA 1 507 284 3594 1 507 284 1161
    Expert Opin Med Diagn 1:299-302. 2007
  8. pmc Preeclampsia and the future risk of hypertension: the pregnant evidence
    Vesna D Garovic
    Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
    Curr Hypertens Rep 15:114-21. 2013
  9. pmc Batch effect correction for genome-wide methylation data with Illumina Infinium platform
    Zhifu Sun
    Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street, Rochester, MN 55905, USA
    BMC Med Genomics 4:84. 2011
  10. ncbi request reprint Urinary podocyte excretion as a marker for preeclampsia
    Vesna D Garovic
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    Am J Obstet Gynecol 196:320.e1-7. 2007

Collaborators

Detail Information

Publications36

  1. ncbi request reprint Hypertension in pregnancy: an emerging risk factor for cardiovascular disease
    Vesna D Garovic
    Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, 200 First Street South West, Rochester, MN 55905, USA
    Nat Clin Pract Nephrol 3:613-22. 2007
    ..Women at high risk must be monitored closely for conventional risk factors that are common to both CVD and hypertensive disorders of pregnancy and treated according to current evidence-based national guidelines...
  2. ncbi request reprint 23-year-old man with hypertension and flank trauma
    Guilherme H M Oliveira
    Mayo Graduate School of Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 77:1229-32. 2002
  3. ncbi request reprint Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia
    Vesna D Garovic
    Division of Nephrology and Hypertension Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
    Nephrol Dial Transplant 22:1136-43. 2007
    ..We sought to test the hypothesis that proteinuria in preeclampsia is associated with dysregulated expression of the podocyte cytoskeleton and/or tight junction proteins...
  4. pmc Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause
    Virginia M Miller
    Departments of Surgery and Physiology and Biomedical Engineering, 200 1st St SW, Rochester, MN 55905, USA
    Biol Sex Differ 4:6. 2013
    ..Research into specific sex differences for these disease processes with attention to an individual's sex chromosomal complement and hormonal status is important and timely...
  5. pmc Mass spectrometry as a novel method for detection of podocyturia in pre-eclampsia
    Vesna D Garovic
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA
    Nephrol Dial Transplant 28:1555-61. 2013
    ....
  6. pmc Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study
    Iasmina M Craici
    Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Hypertension 61:1289-96. 2013
    ..Screening for podocyturia at the end of the second trimester may allow for accurate identification of pregnant women at risk for preeclampsia...
  7. doi request reprint Method of diagnosing pre-eclampsia
    Steven J Wagner
    Mayo Clinic, Division of Nephrology and Hypertension, 200 First Street SW, Rochester, Minnesota 55905, USA 1 507 284 3594 1 507 284 1161
    Expert Opin Med Diagn 1:299-302. 2007
    ..The prospect of developing a laboratory test for the diagnosis of pre-eclampsia is exciting, as is the possibility for risk-stratification and potential therapies...
  8. pmc Preeclampsia and the future risk of hypertension: the pregnant evidence
    Vesna D Garovic
    Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
    Curr Hypertens Rep 15:114-21. 2013
    ....
  9. pmc Batch effect correction for genome-wide methylation data with Illumina Infinium platform
    Zhifu Sun
    Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street, Rochester, MN 55905, USA
    BMC Med Genomics 4:84. 2011
    ..To date, little attention has been given to issues related to normalization and batch effect correction for this kind of data...
  10. ncbi request reprint Urinary podocyte excretion as a marker for preeclampsia
    Vesna D Garovic
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    Am J Obstet Gynecol 196:320.e1-7. 2007
    ..We also aimed to compare the test characteristics of podocyturia to those angiogenic factors that have been shown to play an important role in the pathogenesis of preeclampsia (s-Flt-1, PlGF, and endoglin)...
  11. ncbi request reprint Images in clinical medicine. Nephrogenic fibrosing dermopathy
    Vesna D Garovic
    Mayo Clinic, Rochester, MN 55905, USA
    N Engl J Med 357:e2. 2007
  12. pmc Hypertension in pregnancy as a risk factor for cardiovascular disease later in life
    Vesna D Garovic
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Hypertens 28:826-33. 2010
    ..We aimed to assess the role of hypertension in pregnancy as an independent risk factor for hypertension, coronary heart disease (CHD), and stroke later in life...
  13. doi request reprint Comparison of gadodiamide-enhanced MR angiography to intraarterial digital subtraction angiography for evaluation of renal artery stenosis: results of a phase III multicenter trial
    Vesna D Garovic
    Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA
    J Magn Reson Imaging 31:390-7. 2010
    ....
  14. ncbi request reprint Diabetes insipidus and anterior pituitary insufficiency as presenting features of Wegener's granulomatosis
    V D Garovic
    Divisions of Hypertension, Nephrology, Endocrinology, and Pulmonary Medicine and Critical Care and the Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am J Kidney Dis 37:E5. 2001
    ..Early diagnosis and treatment may be crucial in preventing pituitary gland destruction and long-term endocrine sequelae. We suggest screening for anterior pituitary failure in the presence of the WG-associated DI...
  15. ncbi request reprint Renovascular hypertension: balancing the controversies in diagnosis and treatment
    Vesna D Garovic
    Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Cleve Clin J Med 72:1135-44, 1146-7. 2005
    ..Which noninvasive diagnostic test should be considered, and when is renal angiography called for? Which patients will benefit from conservative medical therapy, and when is PTRA appropriate?..
  16. ncbi request reprint Labile hypertension, increased metanephrines and imaging misadventures
    Vesna D Garovic
    Divisions of Hypertension and Nephrology, Mayo Clinic, Rochester, MN, USA
    Nephrol Dial Transplant 19:1004-6. 2004
  17. ncbi request reprint Monogenic forms of low-renin hypertension
    Vesna D Garovic
    Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Nat Clin Pract Nephrol 2:624-30. 2006
    ....
  18. pmc Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histopathological correlates
    Mira T Keddis
    Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Nephrol Dial Transplant 25:3615-22. 2010
    ..We correlated the histopathological findings and clinical characteristics in selected patients with atherosclerotic RAS who underwent nephrectomy of their small kidneys for resistant renovascular hypertension...
  19. pmc Dietary sodium restriction and beta2-adrenergic receptor polymorphism modulate cardiovascular function in humans
    John H Eisenach
    Department of Anaesthesiology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Physiol 574:955-65. 2006
    ..This study provides evidence that dietary Na+ modulates effects of the Arg16Gly polymorphism on cardiovascular function...
  20. doi request reprint Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes
    Garvan C Kane
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA
    Nephrol Dial Transplant 23:1233-40. 2008
    ..The aim of this study was to assess the results of gadolinium use to facilitate PTRA in patients with chronic kidney disease...
  21. doi request reprint Acute kidney injury in patients with inactive cytochrome P450 polymorphisms
    Nelson Leung
    Mayo Clinic Rochester, Division of Nephrology and Hypertension, Rochester, Minnesota, USA
    Ren Fail 31:749-52. 2009
    ..These are the first two cases of AKI associated with non-functional polymorphisms of cytochrome P450 superfamily. While the exact mechanism has not been worked out, it introduced the possibility of a new source of kidney injury...
  22. ncbi request reprint Revisiting the role of nephrectomy for advanced renovascular disease
    Garvan C Kane
    Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Med 114:729-35. 2003
    ..Despite the advances in antihypertensive therapy and renal revascularization, there remains a group of patients in whom renovascular disease leads to renal atrophy and treatment-resistant hypertension...
  23. ncbi request reprint Renovascular hypertension and ischemic nephropathy
    Vesna D Garovic
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    Circulation 112:1362-74. 2005
  24. doi request reprint Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis
    Garvan C Kane
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
    Nephrol Dial Transplant 25:813-20. 2010
    ..However, the long-term effects of renal artery revascularization on cardiovascular outcomes in HF patients are not well studied...
  25. ncbi request reprint Adverse outcomes of renovascular hypertension during pregnancy
    Bjorg Thorsteinsdottir
    Community Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Nat Clin Pract Nephrol 2:651-6. 2006
    ..The pregnancy was terminated by induction with oxytocin, followed by a vaginal breech delivery. The patient remained hypertensive for 8 weeks after delivery...
  26. ncbi request reprint Acute renal failure in a young weight lifter taking multiple food supplements, including creatine monohydrate
    Bjorg Thorsteinsdottir
    Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55902, USA
    J Ren Nutr 16:341-5. 2006
    ..Further studies are needed to evaluate the safety of creatine supplementation. It may be prudent to include a warning of this possible side effect in the product insert...
  27. pmc Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test?
    Iasmina Craici
    Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Ther Adv Cardiovasc Dis 2:249-59. 2008
    ....
  28. doi request reprint Preeclampsia as a risk factor for cardiovascular disease later in life: validation of a preeclampsia questionnaire
    Courtenay L Diehl
    Division of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Obstet Gynecol 198:e11-3. 2008
    ..This study was undertaken to validate a self-administered questionnaire in verifying the diagnosis of preeclampsia, eclampsia, or toxemia in a group of women with a greater than 20-year history of preeclampsia...
  29. pmc Maternal and foetal outcomes in pregnant patients with active lupus nephritis
    S J Wagner
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA
    Lupus 18:342-7. 2009
    ..031). Active, but not quiescent, lupus nephritis during pregnancy is associated with a higher incidence of maternal and foetal complications compared with pregnancies in SLE patients without renal involvement...
  30. pmc Beta(2)-adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans
    Vesna D Garovic
    Division of Hypertension, Department of Internal Medicine, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
    J Physiol 546:583-9. 2003
    ..In contrast to previous reports based on systemic infusions of beta(2)-agonists, our findings indicate that regional blood flow responses to locally infused isoproterenol are significantly greater in Gly16 than in Arg16 homozygotes...
  31. ncbi request reprint Post-traumatic haemodialysis catheter fracture with bacteraemia
    Kalpathi L Venkatachalam
    Mayo Clinic, Department of Internal Medicine, Rochester, MN, USA
    Nephrol Dial Transplant 18:618-9. 2003
  32. pmc Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension
    Jingfei Cheng
    Department of Experimental Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Am J Physiol Renal Physiol 297:F1055-68. 2009
    ..Notably, an unexpected proliferative response occurs in the stenotic kidney that undergoes atrophy...
  33. ncbi request reprint Hypertensive pregnancy disorders: current concepts
    Steven J Wagner
    Mayo Clinic, Rochester, MN 55905, USA
    J Clin Hypertens (Greenwich) 9:560-6. 2007
    ..This article will provide a brief review of hypertensive pregnancy disorders and important recent discoveries regarding their pathogeneses, while focusing on current diagnostic and treatment strategies...
  34. ncbi request reprint Restenosis following percutaneous renal artery revascularization
    Garvan C Kane
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Nephron Clin Pract 107:c63-9. 2007
    ..The aims of this study were to determine the risk factors for restenosis and to evaluate the blood pressure outcomes of patients who underwent repeat PTRA...
  35. pmc Posterior reversible encephalopathy syndrome and eclampsia: pressing the case for more aggressive blood pressure control
    Steven J Wagner
    Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 86:851-6. 2011
    ..To assess the prevalence, clinical presentations, and neuroimaging abnormalities in a series of patients treated for eclampsia at Mayo Clinic in Rochester, MN...
  36. ncbi request reprint Contrast nephropathy after coronary angiography
    Apoor S Gami
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 79:211-9. 2004
    ..The prevention of contrast nephropathy is crucial for the care of patients undergoing coronary angiography and should be possible with an understanding of risk factors and proven management strategies...